Integrating epidermal growth factor receptor assay with clinical parameters improves risk classification for relapse and survival in head-and-neck squamous cell carcinoma

International Journal of Radiation Oncology Biology Physics

Volumn 81, Issue 2, 2011, Pages 331-338

  Chung, Christine H ^a   Zhang, Qiang ^b   Hammond, Elizabeth M ^c   Trotti III, Andy M ^d   Wang, Huijun ^e   Spencer, Sharon ^f   Zhang, Hua Zhong ^e   Cooper, Jay ^g,h   Jordan, Richard ^j   Rotman, Marvin H ⁱ   Ang, K Kian ^e  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b RTOG Statistical Center   (United States)

^c LDS HOSPITAL   (United States)

^d H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^e UNIVERSITY OF TEXAS   (United States)

^f UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^g NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^h Maimonides Cancer Center   (United States)

ⁱ SUNY DOWNSTATE MEDICAL CENTER   (United States)

^j UNIVERSITY OF CALIFORNIA   (United States)

more..

Author keywords

Epidermal growth factor receptor; Head and neck squamous cell carcinoma; Prognosis; Risk classification

Indexed keywords

CLINICAL PARAMETERS; CLINICAL TRIAL; EPIDERMAL GROWTH FACTOR RECEPTORS; EXPRESSION DATA; HEAD-AND-NECK SQUAMOUS CELL CARCINOMA; IMMUNOHISTOCHEMISTRY; INDEPENDENT PREDICTORS; MICROVESSEL DENSITY; MOLECULAR MARKER; OVER-EXPRESSION; OVERALL SURVIVAL; PERFORMANCE STATUS; PRE-TREATMENT; PROGNOSIS; PROGNOSTIC VARIABLES; RECURSIVE PARTITIONING ANALYSIS; RELATIVE RISKS; RISK CLASS; RISK CLASSIFICATION; THERAPEUTIC STRATEGY;

CELLS; PEPTIDES; RADIOTHERAPY; REFINING; REGRESSION ANALYSIS; TUMORS;

RISKS;

EPIDERMAL GROWTH FACTOR RECEPTOR; KI 67 ANTIGEN; PROTEIN P53;

ADULT; AGED; ARTICLE; BIOASSAY; CANCER RELAPSE; FEMALE; HEAD AND NECK CARCINOMA; HUMAN; MAJOR CLINICAL STUDY; MALE; MICROVASCULATURE; OVERALL SURVIVAL; PARAMETER; PRIORITY JOURNAL; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA;

AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; DISEASE-FREE SURVIVAL; DOSE FRACTIONATION; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; KARNOFSKY PERFORMANCE STATUS; KI-67 ANTIGEN; MALE; MICROVESSELS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROPORTIONAL HAZARDS MODELS; RECEPTOR, EPIDERMAL GROWTH FACTOR; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 80052788509     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2010.05.024     Document Type: Article

References (42)

1. J. Bourhis, J. Overgaard, and H. Audry Hyperfractionated or accelerated radiotherapy in head and neck cancer: A meta-analysis Lancet 368 2006 843 854 (Pubitemid 44292807)
2. J. Pignon, J. Bourhis, and C. Domenge Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: Three meta-analyses of updated individual data Lancet 355 2000 949 955 (Pubitemid 30148259)
3. G. Calais, M. Alfonsi, and E. Bardet Randomized trial of radiation therapy versus concomitant chemotherapy and radiation therapy for advanced-stage oropharynx carcinoma. [see comments.] J Natl Cancer Inst 91 1999 2081 2086 (Pubitemid 30019568)
4. D.J. Adelstein, Y. Li, and G.L. Adams An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer J Clin Oncol 21 2003 92 98
5. A.A. Forastiere, H. Goepfert, and M. Maor Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer N Engl J Med 349 2003 2091 2098 (Pubitemid 37464533)
6. J. Bernier, C. Domenge, and M. Ozsahin Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer N Engl J Med 350 2004 1945 1952 (Pubitemid 38580197)
7. J.S. Cooper, T.F. Pajak, and A.A. Forastiere Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck N Engl J Med 350 2004 1937 1944
8. M.R. Posner, D.M. Hershock, and C.R. Blajman Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer N Engl J Med 357 2007 1705 1715 (Pubitemid 350005152)
9. J.B. Vermorken, J. Trigo, and R. Hitt Open-label, uncontrolled, multicenter phase II study to evaluate the efficacy and toxicity of cetuximab as a single agent in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck who failed to respond to platinum-based therapy J Clin Oncol 25 2007 2171 2177 (Pubitemid 46954639)
10. F. Denis, P. Garaud, and E. Bardet Late toxicity results of the GORTEC 94-01 randomized trial comparing radiotherapy with concomitant radiochemotherapy for advanced-stage oropharynx carcinoma: comparison of LENT/SOMA, RTOG/EORTC, and NCI-CTC scoring systems Int J Radiat Oncol Biol Phys 55 2003 93 98 (Pubitemid 36020347)
11. M. Maurizi, G. Almadori, and G. Ferrandina Prognostic significance of epidermal growth factor receptor in laryngeal squamous cell carcinoma Br J Cancer 74 1996 1253 1257 (Pubitemid 26360115)
12. J. Grandis, M. Melhem, and W. Gooding Levels of TGF-alpha and EGFR protein in head and neck squamous cell carcinoma and patient survival J Natl Cancer Inst 90 1998 824 832 (Pubitemid 28280548)
13. K.K. Ang, B.A. Berkey, and X. Tu Impact of epidermal growth factor receptor expression on survival and pattern of relapse in patients with advanced head and neck carcinoma Cancer Res 62 2002 7350 7356 (Pubitemid 36025259)
14. D.T. Chua, J.M. Nicholls, and J.S. Sham Prognostic value of epidermal growth factor receptor expression in patients with advanced stage nasopharyngeal carcinoma treated with induction chemotherapy and radiotherapy Int J Radiat Oncol Biol Phys 59 2004 11 20 (Pubitemid 38501502)
15. J.G. Eriksen, T. Steiniche, and J. Askaa The prognostic value of epidermal growth factor receptor is related to tumor differentiation and the overall treatment time of radiotherapy in squamous cell carcinomas of the head and neck Int J Radiat Oncol Biol Phys 58 2004 561 566 (Pubitemid 38142484)
16. S.M. Bentzen, B.M. Atasoy, and F.M. Daley Epidermal growth factor receptor expression in pretreatment biopsies from head and neck squamous cell carcinoma as a predictive factor for a benefit from accelerated radiation therapy in a randomized controlled trial J Clin Oncol 23 2005 5560 5567
17. A. Psyrri, Z. Yu, and P.M. Weinberger Quantitative determination of nuclear and cytoplasmic epidermal growth factor receptor expression in oropharyngeal squamous cell cancer by using automated quantitative analysis Clin Cancer Res 11 2005 5856 5862 (Pubitemid 41170313)
18. L. Milas, K. Mason, and N. Hunter In vivo enhancement of tumor radioresponse by C225 antiepidermal growth factor receptor antibody Clin Cancer Res 6 2000 701 708 (Pubitemid 30111496)
19. S.M. Huang, and P.M. Harari Modulation of radiation response after epidermal growth factor receptor blockade in squamous cell carcinomas: Inhibition of damage repair, cell cycle kinetics, and tumor angiogenesis Clin Cancer Res 6 2000 2166 2174 (Pubitemid 30399181)
20. K. Dittmann, C. Mayer, and B. Fehrenbacher Radiation-induced epidermal growth factor receptor nuclear import is linked to activation of DNA-dependent protein kinase J Biol Chem 280 2005 31182 31189 (Pubitemid 41291855)
21. H. Raybaud-Diogene, A. Fortin, and R. Morency Markers of radioresistance in squamous cell carcinomas of the head and neck: A clinicopathologic and immunohistochemical study J Clin Oncol 15 1997 1030 1038 (Pubitemid 27106287)
22. C. Couture, H. Raybaud-Diogene, and B. Tetu p53 and Ki-67 as markers of radioresistance in head and neck carcinoma Cancer 94 2002 713 722 (Pubitemid 34132300)
23. N. Weidner, J.P. Semple, and W.R. Welch Tumor angiogenesis and metastasis: Correlation in invasive breast carcinoma N Engl J Med 324 1991 1 8
24. K.K. Fu, T.F. Pajak, and A. Trotti A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: First report of RTOG 9003 Int J Radiat Oncol Biol Phys 48 2000 7 16 (Pubitemid 30488207)
25. D.P. Calvin, M.E. Hammond, and T.F. Pajak Microvessel density >or=60 does not predict for outcome after radiation treatment for locally advanced head and neck squamous cell carcinoma: results of a correlative study from the Radiation Therapy Oncology Group (RTOG) 90-03 Trial Am J Clin Oncol 30 2007 406 419 (Pubitemid 47356686)
26. E.L. Kaplan, and P. Meier Nonparametric estimation from incomplete observations J Am Stat Assoc 53 1958 457 481
27. N. Mantel Evaluation of survival data and two new rank order statistics arising in its consideration Cancer Chemother Rep 50 1966 163 170
28. J. Kalbfleish, and R. Prentice The statistical analysis of failure time data 1980 John Wiley and Sons New York
29. S.J. Gray Towards a theory of cultural influence on the development of accounting of accounting systems internationally Abacus 24 1988 1 15
30. M. Hollander, and D.A. Wolfe Nonparametric statistical methods 1973 John Wiley & Sons New York
31. K. Pearson On the criterion that a given system of deviations from the probable in the case of correlated system of variables is such that it can be reasonably supposed to have arisen from random sampling Philosophical Magazine 53 1900 157 175
32. W. Kruskal, and W.A. Wallis Use of ranks in one-criterion variance analysis Am Stat Assoc 47 1952 583 621
33. H. Zhang, and B. Singer Recursive partitioning in the health sciences 1999 Springer-Verlag New York
34. I. Schiattino, R. Villegas, and A. Cruzat Multiple imputation procedures allow the rescue of missing data: An application to determine serum tumor necrosis factor (TNF) concentration values during the treatment of rheumatoid arthritis patients with anti-TNF therapy Biol Res 38 2005 7 12 (Pubitemid 40872288)
35. J.P. Shah, R.A. Cendon, and H.W. Farr Carcinoma of the oral cavity. factors affecting treatment failure at the primary site and neck Am J Surg 132 1976 504 507
36. J.T. Johnson, E.L. Barnes, and E.N. Myers The extracapsular spread of tumors in cervical node metastasis Arch Otolaryngol 107 1981 725 729 (Pubitemid 12245989)
37. L.J. Peters, H. Goepfert, and K.K. Ang Evaluation of the dose for postoperative radiation therapy of head and neck cancer: First report of a prospective randomized trial Int J Radiat Oncol Biol Phys 26 1993 3 11 (Pubitemid 23137882)
38. K.D. Olsen, M. Caruso, and R.L. Foote Primary head and neck cancer: Histopathologic predictors of recurrence after neck dissection in patients with lymph node involvement Arch Otolaryngol Head Neck Surg 120 1994 1370 1374 (Pubitemid 24378580)
39. R.L. Carter, N.S. Tanner, and P. Clifford Perineural spread in squamous cell carcinomas of the head and neck: A clinicopathological study Clin Otolaryngol Allied Sci 4 1979 271 281 (Pubitemid 9254350)
40. K. Ang, R. Weber, and E. Vokes Radiation Therapy Oncology Group. Research Plan 2002-2006. Head and Neck Cancer Committee Int J Radiat Oncol Biol Phys 51 2001 39 43
41. M. Gillison, Q. Zhang, and K.K. Ang Analysis of the effect of p16 and tobacco pack-years (p-y) on overall (OS) and progression-free survival (PFS) for patients with oropharynx cancer (OPC) in radiation therapy oncology group (RTOG) protocol 9003 Proc Am Soc Clin Oncol 28 2010 Abst#5510
42. M.L. Poeta, J. Manola, and M.A. Goldwasser TP53 mutations and survival in squamous cell carcinoma of the head and neck N Engl J Med 357 2007 2552 2561 (Pubitemid 350294222)